WASHINGTON–Authorities have arrested more than 124 individuals in the United States on federal charges as the result of an international investigation targeting the illegal manufacturing and trafficking of anabolic steroids and its raw materials, mainly from China,along with the human growth hormone (HGH) and the insulin growth factor (IGF) markets, the
Department of Justice announced today.
These law enforcement operations were the result of Operation Raw Deal, the largest steroid enforcement action in U.S. history. The nearly two-year-old operation, which culminated in a series of law enforcement actions last week, was led by the Drug Enforcement
Administration (DEA), working with federal law enforcement officials from the Food and Drug Administration’s (FDA) Office of Criminal Investigations, the U.S. Postal Inspection Service, and others. The Internal Revenue Service (IRS), U.S. Immigrations and Customs Enforcement
(ICE), Federal Bureau of Investigation (FBI) and the National Drug Intelligence Center (NDIC) also played key roles in Operation Raw Deal. The multi-jurisdictional Organized Crime Drug
Enforcement Task Force (OCDETF) operation was coordinated by prosecutors from the Criminal Division’s Narcotic and Dangerous Drug Section assigned to the Special Operations Division. The U.S. operation took place in conjunction with enforcement operations in Mexico, Canada, China, Belgium, Australia, Germany, Denmark, Sweden, and Thailand.
To read more, please see the full press release attached. With questions on the cases against the defendants charged in the Southern District of New York, please call the U.S. Attorney’s Office for the Southern District of New York’s Press Office: (212) 637-2600.
